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Recently, PIWIL4 has been identiﬁed as a functional protein involved in tumorigenesis. Cervical can-
cer is the second most prevalent form of cancer worldwide. The relationship between PIWIL4 and
cervical cancer is still unknown. Here, we found that PIWIL4 is up-regulated in human cervical can-
cer tissues in comparison to adjacent normal tissues, and it promotes cell growth and proliferation
by inhibiting apoptosis through the p14ARF/p53 pathway. PIWIL4 can also promote the invasion of
cervical cancer cells. These results suggest that PIWIL4 might play an oncogenic role in cervical can-
cer and be useful as a new therapeutic target in the future.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cervical cancer is the second most cause of cancer among
women worldwide [1]. In most developing countries there are no
organized screening and diagnostic programs. Previous studies
have reported cervical cancer is a complex disease in which the
expression of many speciﬁc genes, known as oncogenes or tumor
suppressors, is abnormally changed [2–5]. For example, the PIK3CA
gene, which is involved in the PI3-kinase/AKT signaling pathway, is
up-regulated in cervical cancer due to the ampliﬁcation of the
chromosome 3q26.3 locus [4]. In addition, the tumor suppressor
gene phosphatase and tensin homolog (PTEN) is down-regulated
due to genetic mutation or deletion [5]. However, common molec-
ular mechanisms of cervical carcinogenesis remain to be eluci-
dated. Therefore, it is crucial to identify speciﬁc molecular
markers for the detection and identiﬁcation of the mechanisms
that contribute to the cervical carcinogenesis.chemical Societies. Published by E
N, phosphatase and tensin
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g-Tai Road, Tianjin 300070,The Argonaute protein family was ﬁrst discovered in plants, and
members are deﬁned by the PAZ (Piwi-Argonaute-Zwille) and PIWI
domains [6]. Argonaute proteins are highly conserved between
species and can be divided into Ago and Piwi subclades. The Ago
subfamily is ubiquitously expressed in embryonic and adult tissues
[7–10], and members of the Piwi subfamily are primarily expressed
in the testis or in embryonic tissues [11,12]. In humans, there are
four members of the PIWI-like family, PIWIL1, PIWIL2, PIWIL3,
and PIWIL4 [13]. Over the past few years, evidence has demon-
strated that the Argonaute family has important functions in
embryonic development, cell differentiation and transposon
silencing. However, several reports recently revealed that PIWI
proteins may participate in germ cell proliferation and their over-
expression may cause the development of germ cell malignancies
[10]. PIWIL1–4 was also shown to be highly expressed in tumorous
colon tissues, and they may promote tumor invasion [13,14].
Among them, PIWIL4 might play unique roles in tumorigenesis
and exhibit a ubiquitous expression pattern in various types of
cancers, including colon and breast cancers [14–16]. However,
the expression and function of PIWIL4 in cervical cancer remain
unclear.
Here, we report that PIWIL4 is up-regulated in cervical carci-
noma tissues in comparison to adjacent normal cervical tissues.
Furthermore, PIWIL4 can promote cell growth and inhibit cell
apoptosis in cervical cancer cells through the p14ARF/p53
pathway. Moreover, we also found that PIWIL4 can promote celllsevier B.V. All rights reserved.
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oncogene in cervical carcinoma.2. Materials and methods
2.1. Human tissue samples
Paired human cervical tissues and adjacent normal tissues from
18 cervical cancer patients were obtained from the Tumor Bank
Facility of Tianjin Medical University Cancer Institute and Hospital
and the National Foundation of Cancer Research (TBF of TMUCIH &
NFCR). The stages of cancer were Ib to Ia. Histologically, all of the
biopsies were squamous cell carcinomas. All of the humanmaterial
used was approved and supervised by the Ethics Committee of
Tianjin medical university. The specimens were frozen in liquid
nitrogen and stored at 80 C until investigation.
2.2. RNA preparation and qRT-PCR analysis
Total RNA was extracted using Trizol reagent (Invitrogen, Carls-
bad, CA) according to the manufacturer’s instructions. Five micro-
grams of total RNA was reverse transcribed to cDNA using oligo
(dT) primers and M-MLV reverse transcriptase (Promega, Madison,
WI). Quantitative real time PCR (qRT-PCR) analysis was performed
to detect the expression level of PIWIL4, p14ARF and bak in tripli-
cate with the SYBR Premix Ex TaqTM Kit (TaKaRa, Dalian, China),
according to the manufacturer’s instructions. b-actin levels were
used as normalizer. The following primers were used: PIWIL4-
sense, 50-CATGAACTACTGGCATCAC-30, PIWIL4-antisense, 50-GGG
AATTAGACTCTGTTTATC-30; p14ARF-sense, 50-GCGTGGGTCCCAGTC
TGCA-30, p14ARF-antisense, 50-GCGGGATGTGAACCACGAA-30; bak-
sense, 50-CTCAGTTCTCTCCCTTCC-30, bak-antisense, 50-CTCCCTACTC
CTTTTCCC-30; b-actin-sense, 50-CGTGACATTAAGGAGAAGCTG-30, b-
actin-antisense, 50-CTAGAAGCATTTGCGGTGGAC-30. PCR was per-
formed by denaturing the DNA at 94 C for 4 min, followed by 40
cycles of ampliﬁcation: 94 C for 60 s, 58 C for 60 s, 72 C for
60 s for data collection.
2.3. Construction of vectors
The CDS of human PIWIL4 was ampliﬁed from human HeLa
cDNA by PCR using the following oligonucleotide primers: sense:
50-CGCGGATCCACCATGAGTGGAAGAGCCCGAGTG-30 and anti-
sense: 50-CTCCGCTCGAGGCCAGGTAGAAGAGATGGTTGGCAT-30.
PCR was performed by denaturing the DNA at 94 C for 4 min, fol-
lowed by 33 cycles of ampliﬁcation: 94 C for 1 min, 63 C for
3 min, 72 C for 1 min, and a ﬁnal extension step at 72 C for
10 min. Then, the PCR product was cloned into the BamHI/XhoI
restriction sites of pcDNA3. Finally, the resulting pcDNA3/PIWIL4
construct was conﬁrmed by DNA sequencing. To construct the pSi-
lencer2.1/PIWIL4-shRNA and pSilencer2.1/p14ARF-shRNA vectors,
a 70-bp double-strand fragment was obtained via an annealing
reaction using two single-strands designed by Deqor (at http://
cluster-1.mpi-cbg.de/Deqor/deqor.html): PIWIL4-shRNA-Top, GA
TCCGGCTCCTGTTTAGTGCTGATGTTTCAAGAGAACATCAGCACTAAAC
AGGAGCTTTTTTGGAAGAATTCA; PIWIL4-shRNA-Bot, AGCTTGAA
TTCTTCCAAAAAAGCTCCTGTTTAGTGCTGATGTTCTCTTGAAACATCA
GCACTAAACAGGAGCCG; p14ARF-shRNA-Top, GATCCGCGCACC-
GAATAGTTACGGTTTCAAGAGAACCGTAACTATTCGGTGCGTTTTTTG-
GAAGAATTCA and p14ARF-shRNA-Bot, AGCTTGAATTCTTCCAAA
AAACGCACCGAATAGTTACGGTTCTCTTGAAACCGTAACTATTCGGTG
CGCG. The fragment was then cloned into pSilencer 2.1 using the
BamHI and HindIII sites. The negative control pSilencer2.1/NC ex-
presses a hairpin shRNA with limited homology to all known se-
quences in the human genome.2.4. Cell culture and transfection
The human cervical cancer cell lines, HeLa and C33A, were
grown in RPMI-1640 medium supplemented with 10% (v/v) heat-
inactivated FBS, 100 IU/ml of penicillin and 100 lg/ml of strepto-
mycin under a humidiﬁed atmosphere of 95% air and 5% CO2 at
37 C. Transfection was performed with Lipofectamine 2000 re-
agent (Invitrogen, Carlsbad, CA) following the manufacturer’s
protocol.
2.5. Western blot analysis
Cells were lysed in RIPA buffer, and lysates were analyzed by a
standard western blot procedure [17]. Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was used as an endogenous nor-
malizer. The rabbit anti-human GAPDH, PIWIL4, p14ARF and p53
primary antibodies were from Saierbio (Tianjin, China) and rabbit
anti-human bak were from Santa Cruz Biotechnology (California,
USA).
2.6. Cell cycle and apoptosis assays
Transfected HeLa cells were seeded into 6-well plates for 24 h in
complete medium. Next, cells were deprived of serum for 48 h and
then returned to complete medium for an additional 24 h. All cells
were collected by centrifugation, ﬁxed in 95% ethanol, incubated at
20 C overnight and washed with phosphate buffered saline
(PBS). Then, cells were resuspended in 1 ml of FACS solution
(PBS, 0.1% TritonX-100, 60 lg/ml propidium iodide (PI), 0.1 mg/
ml DNase free RNase, and 0.1% trisodium citrate). After a ﬁnal incu-
bation on ice for 30 min, cells were analyzed using a FACS Calibur
ﬂow cytometer (Beckman Coulter). A total of 10,000 events were
counted for each sample. For apoptosis assay, HeLa cells were
transfected with pcDNA3/PIWIL4 or pSilencer2.1/PIWIL4-shRNA
and seeded into triplicate wells on a 14-well slide (Cell-Line/Erie
Scientiﬁc Co., NH, USA) at 48 h post-transfection. Next, cell apopto-
sis was detected using the In situ Cell Death Detection Kit and Fluo-
rescein (Roche Applied Science, IN, USA) according to the
manufacturer’s instructions. DAPI staining was used to determine
the number of nuclei and to assess gross cellular morphology.
2.7. Cell invasion assay
Invasion assays were performed in 24-well transwell chambers
(Corning, Cambridge, MA, USA), as previously described [18]. Pre-
chilled serum-free RPMI1640 was mixed with Matrigel (1:7; BD
Biosciences, Franklin Lakes, USA). The upper compartments of
the chambers were ﬁlled with 100 ll of the mixture, and the
Matrigel was allowed to solidify at room temperature for 4 h.
After solidiﬁcation, 5  104 HeLa cells or 8  104 C33A cells were
trypsinized, washed, resuspended in serum-free RPMI1640 and
seeded in the top portion of the chamber. Another 500 ll of
RPMI1640 containing 10% FBS was added to the lower portion
of the chamber as a chemoattractant. The chambers were incu-
bated at 37 C in 5% CO2 for 24 h (HeLa cells) or 48 h (C33A cells),
washed with PBS, and ﬁxed in 100% methanol. Fixed cells were
stained with crystal violet and photographed, and the number of
invasive cells was counted. Five random ﬁelds were analyzed for
each chamber. Assays were conducted in three independent
experiments.
2.8. Cell biology assays
For a detailed description of the cell culture and cell biology as-
says (MTT assay, colony formation assay, cell growth curve assay),
please see the references [19,20].
Fig. 1. Identiﬁcation of the differential expression of PIWIL4 in cervical tissues. The
expression level of PIWIL4 in eighteen pairs of cervical carcinoma tissues (Ca) and
matched normal tissues (N) was detected by quantitative RT-PCR. b-Actin was used
as endogenous normalizer. The relative expression level of PIWIL4 in the 18 pairs of
cervical tissues as well as the combined result (mean ± SD) is shown. ⁄p < 0.05.
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A Student0s test was performed to analyze the signiﬁcance of
differences between the sample means obtained from three inde-
pendent experiments. Pearson0s correlation was used to analyze
the relationship between two factors. Differences were considered
statistically signiﬁcant at p < 0.05 and p < 0.01.
3. Results
3.1. PIWIL4 is up-regulated in human cervical cancer tissues
In order to investigate the role of PIWIL4 in cervical cancer, we
ﬁrst measured the expression levels of PIWIL4 in 18 pairs of hu-
man cervical cancer tissues and adjacent normal tissues using
qRT-PCR. The results showed that PIWIL4 expression levels were
generally higher in cervical cancer tissues than in matched nor-
mal cervical tissues, with the exception of one paired samples
(Fig. 1).
3.2. Alteration of PIWIL4 affects cervical cancer cell growth in vitro
Given that PIWIL4 is up-regulated in cervical cancer, we asked
whether PIWIL4 had an impact on the growth of cervical cancer
cells. First, we transfected either a PIWIL4 small interfering RNA
expressing vector (pSilencer2.1/PIWIL4-shRNA) or a PIWIL4
expression vector (pcDNA3/PIWIL4) into HeLa cells and detected
PIWIL4 levels by qRT-PCR and western blot. As shown in Fig. 2A,
the mRNA and protein levels of PIWIL4 were obviously increased
in HeLa cells transfected with pcDNA3/PIWIL4 as compared to cells
transfected with pcDNA3. Transfection with pSilencer2.1/PIWIL4-
shRNA resulted in a signiﬁcant reduction in PIWIL4 mRNA and
protein levels comparing to pSilencer2.1/NC (Fig. 2A). Next, MTT
assays were performed to further test the effect of PIWIL4 on the
viability of HeLa cells. The results showed that cells transfected
with pcDNA3/PIWIL4 had increased cell viability, whereas cells
transfected with pSilencer2.1/PIWIL4-shRNA had reduced cell
viability at 48 and 72 h (Fig. 2B). In parallel, colony formation
and cell growth curve assays were used to assess the effect of PI-
WIL4 on the long-term proliferative capacity of HeLa cells. As
shown in Fig. 2C, the colony number of HeLa cells with higher
expression of PIWIL4 increased about twofold than that of control
group. Conversely, the ability of colony formation in HeLa cells
with down-regulated PIWIL4 was 55% lower than that of HeLa cells
transfected with control vectors (Fig. 2C). In addition, cell growth
curve assays showed that the cell proliferation in the pcDNA3/PI-
WIL4 transfection group proliferated more quickly, whereas the
pSilencer2.1/PIWIL4-shRNA transfection group was largely sup-
pressed in comparison to the control group (Fig. 2D). Similar
results were observed in another cervical cancer cell line, C33A
(Fig. 2B–D). These results indicate that PIWIL4 can promote the
growth and proliferation of cervical cancer cells.
3.3. PIWIL4 promotes the invasion of cervical cancer cells in vitro
A previous study has shown that PIWIL4 can promote the
invasion of colon tumor [14]. Therefore, we tested if PIWIL4 was
associated with the invasion of cervical cancer cells using cell inva-
sion assays. Compared to the pcDNA3 control, the number of cells
that migrated through the basement membrane of the transwell
chamber increased approximately twofold in HeLa and C33A cells
transfected with pcDNA3/PIWIL4 after 24 h (HeLa cells) and 48 h
(C33A cells), whereas it decreased 55% in HeLa cells and 30% in
C33A cells transfected with pSilencer2.1/PIWIL4-shRNA in compar-
ison to the control after 24 h or 48 h (Fig. 3), which suggests that
PIWIL4 can promote cervical cancer cell invasion.3.4. PIWIL4 impairs HeLa cells apoptosis without affecting the cell
cycle
To further explore the mechanism of PIWIL4 in promoting cell
growth and proliferation, we investigated the effects of PIWIL4
on cell apoptosis and cell cycle of HeLa cells. Apoptosis cells were
visualized by TUNEL assays, and a representative experiment was
shown in Fig. 4A. The results indicated that cells transfected with
the knockdown construct, pSilencer2.1/PIWIL4-shRNA, showed
more TUNEL-positive cells, and cells transfected with pcDNA3/PI-
WIL4 were attenuated for apoptosis compared to the control group
(Fig. 4A and B). However, there was no signiﬁcant difference in the
cell cycle distribution of cells with different levels of PIWIL4
(Fig. 4C and D) by FACS assays. These results indicate that the
effects of altered PIWIL4 on HeLa cell growth were due to the dis-
regulation of cell apoptosis and not the loss of cell cycle control.
Then we further investigate whether the disregulation of cell
apoptosis caused by different level of PIWIL4 are related to the
expression of bak, a key components in the apoptosis pathway.
QRT-PCR and western blot assays were used to test the mRNA
and protein level of HeLa cells transfected with pcDNA3/PIWIL4
or pSilencer2.1/PIWIL4-shRNA. As shown in Fig. 4E and F, overex-
pression of PIWIL4 reduced the mRNA and protein level of bak,
while knockdown of PIWIL4 increased that of bak.
3.5. Role of PIWIL4 in p14ARF-mediated HeLa cell growth
It has been reported that p16ink4a is a downstream effector of
PIWIL4 [21], so we want to know if p14ARF, a alternative transcript
variant of p16ink4a, is also been regulated by PIWIL4. We evalu-
ated the expression of p14ARF in cervical cancer cells with differ-
ent levels of PIWIL4. As shown in Fig. 5A, a obvious reduction of
p14ARF is observed in cells transfected with pcDNA3/PIWIL4 in
protein and mRNA levels, whereas an clear increase of p14ARF
was observed in cells transfected with pSilencer2.1/PIWIL4-shRNA.
Then we further analyze the expression of p53 by western blot as-
says because p53 has been reported to be a downstream effector of
p14ARF [22,23]. As shown in Fig. 5B, p53 was down-regulated in
cells transfected with pcDNA3/PIWIL4 and up-regulated in cells
transfected with pSilencer2.1/PIWIL4-shRNA.
Next, we explored whether PIWIL4-induced HeLa cell growth
was mediated by p14ARF. In this experiment, we constructed the
knockdown vector of p14ARF, pSilencer2.1/p14ARF-shRNA, which
express speciﬁc siRNAs to inhibit the expression of p14ARF effec-
tively (Fig. 5C). Firstly, we transfected pSilencer2.1/p14ARF-shRNA
Fig. 2. Alteration of PIWIL4 levels affects the HeLa cell growth. (A) The PIWIL4 expression level in HeLa cells was effectively altered by transfection of pcDNA3/PIWIL4 or
pSilencer2.1/PIWIL4-shRNA. PcDNA3 and pSilencer 2.1/NC were used as control vectors. QRT-PCR and western blot were used to detect the mRNA and protein expression of
PIWIL4. b-Actin RNA and GAPDH protein were used for normalization. (B–D) HeLa and C33A cells were transfected with the pSilencer2.1/PIWIL4-shRNA vector or a pcDNA3/
PIWIL4 vector. MTT assays (B) were used to determine the relative cellular proliferation at 48 and 72 h. The cell absorption were measured at 570 nm. Cell growth was also
measured with colony formation assays (C) and growth curve assays (D). The data represent the mean ± SD of three different experiments. ⁄p < 0.05.
Fig. 3. PIWIL4 promotes the invasion ability of HeLa cells in vitro. Transwell
invasion assays were carried out with HeLa and C33A cells transfected with the
pcDNA3/PIWIL4 or pSilencer2.1/PIWIL4-shRNA. The numbers of cells that invaded
through the membrane were counted, and representative images are shown at the
bottom. Data are shown as the mean ± SD from three independent experiments.
⁄⁄p < 0.01.
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p14ARF using MTT, cell colony formation and TUNEL assays. As
shown in Fig. 5D–G, inhibition of p14ARF could signiﬁcantly in-
crease the cell viability, the ability of cell colony formation and re-
duced cell apoptosis. Then we cotransfected pSilencer2.1/PIWIL4-
shRNA and pSilencer2.1/p14ARF-shRNA into HeLa cells and evalu-
ated whether the effects caused by downregulation of PIWIL4 can
be aborted by the knockdown of p14ARF. As shown in Fig. 5D and
E, the inhibition effect in cell growth caused by pSilencer2.1/PI-
WIL4-shRNA can be entirely abrogated by the reduction of
p14ARF through transfection of pSilencer2.1/p14ARF-shRNA. The
TUNEL assays also indicated that inhibition of p14ARF rescued pSi-
lencer2.1/PIWIL4-shRNA-mediated HeLa cell apoptosis (Fig. 5F and
G). We further examined the role of p53 in this process and found
that, transfection of HeLa cells with pSilencer2.1/p14ARF-shRNA,
but not pSilencer2.1/NC, ablated the pSilencer2.1/PIWIL4-shRNA-
induced increase in p53 levels (Fig. 5H). These results suggested
that PIWIL4-induced HeLa cell growth was mediated by down-reg-
ulation of p14ARF and p53.
4. Discussion
The Argonaute family contains Piwi and PAZ subfamilies, which
play multiple biological roles in germline stem cell (GSC) self-re-
newal, RNA silencing, chromatin remodeling, translational regula-
tion in various organisms [24,25]. Recent evidence has shown that
PIWIL2 proteins are widely expressed in tumors and can regulate
genes involved in apoptosis and proliferation [13]. For these rea-
sons, we wanted to determine whether PIWIL4 also involved in
cervical carcinogenesis. To address this question, we ﬁrst examined
the expression of PIWIL4 by qRT-PCR in cervical cancer tissues and
matched adjacent non-tumor tissues. The results showed that the
PIWIL4 level was increased in tumor tissues as compared to
matched normal tissues in 18 matched specimens. We then deter-
mined the effect of PIWIL4 on cervical cancer cell lines HeLa and
C33A, using gain and loss of function approaches. MTT, colony
formation and growth curve assays show that PIWIL4 can increasethe growth of these cells. FACS analysis suggests that PIWIL4 does
not promote the progression of the HeLa cell cycle, whereas the
TUNEL assay indicates that PIWIL4 can inhibit HeLa cell apoptosis.
Therefore, we speculate that PIWIL4 might be a growth-promoting
factor in cervical cancer. We also found that PIWIL4 can promote
HeLa and C33A cell invasion using cell invasion assays. All of these
assays indicates that PIWIL4 functions as an oncogene in cervical
cancer cell lines.
Fig. 4. The effect of PIWIL4 on cell apoptosis and cell cycle of HeLa cells. (A) HeLa cells were transfected with pcDNA3/PIWIL4 or pSilencer2.1/PIWIL4-shRNA and detected by
the In situ Cell Death Detection Kit at 48 h post-transfection. HeLa cells were treated with 20 lg/ml MG132. Fluorescein staining indicated apoptotic cells. DAPI staining was
used to determine the number of nuclei and to assess the gross cellular morphology. (B) Percentage of TUNEL-positive cells. (C, D)The effect PIWIL4 on cell cycle progression
in HeLa cells. The indicated percentages are the average of three experiments. (E and F) The mRNA and protein level of bak was determined by qRT-PCR (E) and western blot
analysis (F) in HeLa cells transfected with pcDNA3/PIWIL4 or pSilencer2.1/PIWIL4-shRNA. pcDNA3 and pSilencer 2.1/NC were used as control vectors. ⁄p < 0.05.
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ing cell growth. It has been reported that PIWIL4 could reduce
p16ink4a expression [21]. P16ink4a is a tumor suppressor encoded
within the human CDKN2A locus on chromosome 9p21 [26–29].
And p14ARF is an alternative product from the CDKN2A locus. Oz-
enne has reported that p14ARF can suppress aberrant cell growth
in response to oncogene activation by activating the transcription
factor p53, which triggers the expression of many apoptosis induc-
ers [30]. In another published report, bak were shown to mediate
p14ARF-induced activation of mitochondria caspases and subse-
quent fragmentation through p53 [22,31]. Based on all of the above
facts, we wondered if p14ARF/p53 pathway was involved in the
regulation of cell growth and apoptosis caused by PIWIL4. Here,
we found that PIWIL4 suppressed the expression of p14ARF, p53
and bak. Moreover, knockdown of p14ARF could not only promote
the HeLa cell growth, but also counteract the inhibitory effect
caused by decreased PIWIL4. Therefore, PIWIL4 might preventapoptosis by inhibiting the p14ARF/p53 pathway and function as
an oncogene.
Regarding the detailed mechanism of PIWIL4-mediated down-
regulation of p14ARF expression, there are some clues. Recent data
demonstrates that the H3K27me3 demethylase JMJD3 contributes
to the activation of the INK4a-ARF locus. JMJD3 is located on chro-
mosome 17 in close vicinity to the p53 gene. Therefore, allelic loss
at chromosome 17, which is a frequent event in tumors, such as
lung, might be an alternative way to inactivate p14ARF. In addition,
evidence showed that Argonaute can mediate low levels of H3K9
methylation [32], and PIWIL4 can induce H3K9 methylation at
the p16ink4a locus [21]. Based on these ﬁndings, future work will
be deﬁning the mechanism of PIWIL4 in down-regulation of
p14ARF.
In summary, we show an oncogenic function for the PIWIL4
protein. Although the mechanism for inducing p14ARF down-reg-
ulation remains to be determined, our results indicate that PIWIL4
Fig. 5. PIWIL4-induced HeLa cell growth was mediated by downregulation of p14ARF and p53. (A and B) The expression of p14ARF (A) and p53 (B) was detected by western
blot analysis in cells with PIWIL4 overexpression or knockdown. GAPDH was used as internal control. (C) Western blot analysis showed that the expression of p14ARF was
successfully suppressed by pSilencer2.1/p14ARF-shRNA. (D–G) HeLa cells were co-transfected with pSilencer2.1/PIWIL4-shRNA and pSilencer2.1/p14ARF-shRNA, and
pSilencer2.1/NC was used as control vector. Then cell growth was analyzed with MTT (D) and colony formation assays (E). Cell apoptosis was detected by TUNEL staining (F).
Percentage of TUNEL-positive cells are shown (G). (F) p53 was measured by western blot 48 h after transfection.⁄p < 0.05.
C. Su et al. / FEBS Letters 586 (2012) 1356–1362 1361participates in the regulation of HeLa cell growth and invasion and
may induce apoptosis through the p14ARF/p53 pathway. These
ﬁndings may help us to understand the molecular mechanism of
tumorigenesis in cervical cancer and may have potentially diag-
nostic and therapeutic value in the future.
Acknowledgments
We thank Tianjin Medical University Cancer Institute and Hos-
pital for providing human cervical cancer tissue samples and the
College of Public Health of Tianjin Medical University for their
technical assistance with ﬂuorescence detection. This work was
supported by the National Natural Science Foundation of China
(Nos. 91029714; 31071191) and the Natural Science Foundation
of Tianjin (09JCZDJC17500).
References
[1] Bedkowska, G.E., Lawicki, S. and Szmitkowski, M. (2009) Molecular markers of
carcinogenesis in the diagnostics of cervical cancer. Postepy Hig. Med. Dosw.
(Online) 63, 99–105.
[2] Rajkumar, T., Sabitha, K., Vijayalakshmi, N., Shirley, S., Bose, M.V., Gopal, G. and
Selvaluxmy, G. (2011) Identiﬁcation and validation of genes involved in
cervical tumourigenesis. BMC Cancer 11.
[3] Hu, X., Schwarz, J.K., Lewis Jr., J.S., Huettner, P.C., Rader, J.S., Deasy, J.O.,
Grigsby, P.W. and Wang, X. (2010) A microRNA expression signature for
cervical cancer prognosis. Cancer Res. 70, 1441–1448.
[4] Ma, Y.Y., Wei, S.J., Lin, Y.C., Lung, J.C., Chang, T.C., Whang-Peng, J., Liu, J.M.,
Yang, D.M., Yang, W.K. and Shen, C.Y. (2000) PIK3CA as an oncogene in cervical
cancer. Oncogene 19, 2739–2744.
[5] Su, T.H., Chang, J.G., Perng, L.I., Chang, C.P., Wei, H.J., Wang, N.M. and Tsai, C.H.
(2000) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1
in cervical cancer. Gynecol. Oncol. 76, 193–199.
[6] Bohmert, K., Camus, I., Bellini, C., Bouchez, D., Caboche, M. and Benning, C.
(1998) AGO1 deﬁnes a novel locus of Arabidopsis controlling leaf
development. EMBO J. 17, 170–180.
[7] Hock, J. and Meister, G. (2008) The Argonaute protein family. Genome Biol. 9.
[8] Zilberman, D., Cao, X.F. and Jacobsen, S.E. (2003) ARGONAUTE4 control of
locus-speciﬁc siRNA accumulation and DNA and histone methylation. Science
299, 716–719.
[9] Zhou, X., Liao, Z., Jia, Q.D., Cheng, L.G. and Li, F. (2007) Identiﬁcation and
characterization of Piwi subfamily in insects. Biochem. Biophys. Res. Commun.
362, 126–131.[10] Kuramochi-Miyagawa, S., Kimura, T., Ijiri, T.W., Isobe, T., Asada, N., Fujita, Y.,
Ikawa, M., Iwai, N., Okabe, M., Deng, W., Lin, H., Matsuda, Y. and Nakano, T.
(2004) Mili, a mammalian member of piwi family gene, is essential for
spermatogenesis. Development 131, 839–849.
[11] Ye, Y., Yin, D.T., Chen, L., Zhou, Q.S., Shen, R.L., He, G., Yan, Q.T., Tong, Z.Y.,
Issekutz, A.C., Shapiro, C.L., Barsky, S.H., Lin, H.F., Li, J.J. and Gao, J.X. (2010)
Identiﬁcation of Piwil2-Like (PL2L) proteins that promote tumorigenesis. Plos
One 5.
[12] Kawaoka, S., Minami, K., Katsuma, S., Mita, K. and Shimada, T. (2008)
Developmentally synchronized expression of two Bombyx mori Piwi
subfamily genes, SIWI and BmAGO3 in germ-line cells. Biochem. Biophys.
Res. Commun. 367, 755–760.
[13] Lee, J.H., Schutte, D., Wulf, G., Fuzesi, L., Radzun, H.J., Schweyer, S., Engel, W.
and Nayernia, K. (2006) Stem-cell protein Piwil2 is widely expressed in
tumors and inhibits apoptosis through activation of Stat3/Bcl-X–L pathway.
Hum. Mol. Genet. 15, 201–211.
[14] Li, L., Yu, C.H., Gao, H.J. and Li, Y.M. (2010) Argonaute proteins: potential
biomarkers for human colon cancer. BMC Cancer 10.
[15] Nikpour, P., Forouzandeh-Moghaddam, M., Ziaee, S.A., Dokun, O.Y., Schulz,
W.A. and Mowla, S.J. (2009) Absence of PIWIL2 (HILI) expression in human
bladder cancer cell lines and tissues. Cancer Epidemiol. 33, 271–
275.
[16] Coley, W., Van Duyne, R., Carpio, L., Guendel, I., Kehn-Hall, K., Chevalier, S.,
Narayanan, A., Luu, T., Lee, N., Klase, Z. and Kashanchi, F. (2010) Absence of
DICER in monocytes and its regulation by HIV-1. J. Biol. Chem. 285, 31930–
31943.
[17] Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A.,
Egia, A., Sasaki, A.T., Thomas, G., Kozma, S.C., Papa, A., Nardella, C., Cantley, L.C.,
Baselga, J. and Pandolﬁ, P.P. (2008) Inhibition of mTORC1 leads to MAPK
pathway activation through a PI3K-dependent feedback loop in human cancer.
J. Clin. Invest. 118, 3065–3074.
[18] Zhi, X., Chen, S., Zhou, P., Shao, Z., Wang, L., Ou, Z. and Yin, L. (2007) RNA
interference of ecto-50-nucleotidase (CD73) inhibits human breast cancer cell
growth and invasion. Clin. Exp. Metastasis 24, 439–448.
[19] Wan, H.Y., Guo, L.M., Liu, T., Liu, M., Li, X. and Tang, H. (2010) Regulation of the
transcription factor NF-kappa B1 by microRNA-9 in human gastric
adenocarcinoma. Mol. Cancer 9.
[20] Liu, Z., Qiu, M., Tang, Q.L., Liu, M., Lang, N. and Bi, F. (2010) Establishment and
biological characteristics of oxaliplatin-resistant human colon cancer cell
lines. Chin. J. Cancer. 29, 661–667.
[21] Sugimoto, K., Kage, H., Aki, N., Sano, A., Kitagawa, H., Nagase, T., Yatomi, Y.,
Ohishi, N. and Takai, D. (2007) The induction of H3K9 methylation by PIWIL4
at the p16(Ink4a) locus. Biochem. Biophys. Res. Commun. 359, 497–
502.
[22] Hemmati, P.G., Guner, D., Gillissen, B., Wendt, J., von Haefen, C., Chinnadurai,
G., Dorken, B. and Daniel, P.T. (2006) Bak functionally complements for loss of
Bax during p14(ARF)-induced mitochondrial apoptosis in human cancer cells.
Oncogene 25, 6582–6594.
1362 C. Su et al. / FEBS Letters 586 (2012) 1356–1362[23] Brennan, R.C., Federico, S., Bradley, C., Zhang, J.K., Flores-Otero, J., Wilson, M.,
Stewart, C., Zhu, F.Y., Guy, K. and Dyer, M.A. (2011) Targeting the p53 pathway
in retinoblastoma with subconjunctival nutlin-3a. Cancer Res. 71, 4205–
4213.
[24] Thomson, T. and Lin, H. (2009) The biogenesis and function of PIWI proteins
and piRNAs: progress and prospect. Annu. Rev. Cell Dev. Biol. 25, 355–
376.
[25] De Mulder, K., Kuales, G., Pﬁster, D., Willems, M., Egger, B., Salvenmoser, W.,
Thaler, M., Gorny, A.K., Hrouda, M., Borgonie, G. and Ladurner, P. (2009)
Characterization of the stem cell system of the acoel Isodiametra pulchra. BMC
Dev. Biol. 9, 69.
[26] Venneti, S., Le, P., Martinez, D., Biegel, J.A., Pawel, B. and Judkins, A.R. (2010)
P16INK4A and p14ARF tumor suppressor pathways are deregulated in
malignant rhabdoid tumors. Brain Pathol. 20. 72-72.
[27] Wang, Y., Guan, Y.Q., Wang, F., Huang, A.H., Wang, S.Y. and Zhang, Y.A. (2010)
Bmi-1 regulates self-renewal, proliferation and senescence of human fetal
neural stem cells in vitro. Neurosci. Lett. 476, 74–78.[28] Schinke, C., Mo, Y.K., Yu, Y.T., Amiri, K., Sosman, J., Greally, J. and Verma, A.
(2010) Aberrant DNA methylation in malignant melanoma. Melanoma Res. 20,
253–265.
[29] Lang, J.M., Shennan, M., Njauw, J.C.N., Luo, S., Bishop, J.N., Harland, M.,
Hayward, N.K., Tucker, M.A., Goldstein, A.M., Landi, M.T., Puig, S., Gruis, N.A.,
Bergman, W., Bianchi-Scarra, G., Ghiorzo, P., Hogg, D. and Tsao, H. (2011) A
ﬂexible multiplex bead-based assay for detecting germline CDKN2A and CDK4
variants in melanoma-prone kindreds. J. Invest. Dermatol. 131, 480–486.
[30] Ozenne, P., Eymin, B., Brambilla, E. and Gazzeri, S. (2010) The ARF tumor
suppressor: structure, functions and status in cancer. Int. J. Cancer 127, 2239–
2247.
[31] Hemmati, P.G., Gillissen, B., von Haefen, C., Wendt, J., Starck, L., Guner, D.,
Dorken, B. and Daniel, P.T. (2002) Adenovirus-mediated overexpression of
p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene 21, 3149–
3161.
[32] Halic, M. and Moazed, D. (2010) Dicer-independent primal RNAs trigger RNAi
and heterochromatin formation. Cell 140, 504–516.
